Ratings Surperformance

Trader
Investor
Global
Quality
ESG MSCI
BBB
Ratings Surperformance© - Barry Callebaut AG

Ratings ESG MSCI

Ratings ESG MSCI - Barry Callebaut AG

Ratings Barry Callebaut AG: Strengths and Weaknesses

  • On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Highlights: Barry Callebaut AG
  • The company has a low valuation given the cash flows generated by its activity.
  • Historically, the company has been releasing figures that are above expectations.
Weaknesses: Barry Callebaut AG
  • The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • One of the major weak points of the company is its financial situation.
  • With a 2026 P/E ratio at 30.59 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • Over the past twelve months, analysts' opinions have been revised negatively.

Rating Financials

Barry Callebaut AG SectorUnited Kingdom

Fundamentals

Growth

Revenue growth

EPS growth

FCF growth

Profitability

EBITDA Margin

EBIT Margin

Net Margin

Capital Efficiency

ROA

ROCE

ROE

Financial Health

Gearing

Leverage

Capital Intensity

Balance sheet growth

Long Term balance sheet growth

Long term revenue growth

Long term EPS growth

More ratings
Fundamental Rankings - Barry Callebaut AG

Rating Valuation

Barry Callebaut AG SectorUnited Kingdom

Global Valuation

Enterprise Value

EV/Revenue

EV/EBITDA

EV/FCF

Equity Valuation

P/E

PBR

Dividend Yield

EV/EBIT

CAPEX/Revenue

More ratings
Fundamental Rankings - Barry Callebaut AG

Rating Consensus

Barry Callebaut AG SectorUnited Kingdom

Consensus

Analysts' buy/sell recommendations

Analysts' recommendations evolution (1 year)

Analysts' recommendations evolution (4 months)

Analysts' target price

Analysts' target price evolution (1 year)

Analysts' target price evolution (4 months)

Analysts' recommendations evolution (7 days)

Target Price evolution (7 days)

More ratings
Fundamental Rankings - Barry Callebaut AG

Rating Business Predictability

Barry Callebaut AG SectorUnited Kingdom

Visibility

Analysts' coverage

Financial estimates divergence

Analysts' recommendations divergence

Analysts' Target price divergence

Surprise rates

Fundamental Rankings - Barry Callebaut AG

Rating Revisions

Barry Callebaut AG SectorUnited Kingdom

Financial revisions

Revenue revisions (1 year)

Revenue revisions (4 months)

EPS revisions (1 year)

EPS revisions (4 months)

EPS revisions (7 days)

Revenue revisions (7 days)

More ratings
Fundamental Rankings - Barry Callebaut AG


Capi.($) Investor ESG MSCI Fundamentals Financial revisions Global Valuation Visibility Consensus
7B
BBB
235B
AA
77.1B
A
42.28B
AAA
38.5B
AA
32.7B
A
32.55B
AA
28.9B
AA
26.41B
AA
-
26.56B
BBB
- -
Average 54.74B
AA
Weighted average by Cap.
AA